inVentiv Health, a global provider of clinical, commercial and consulting services, has appointed Raymond Hill as executive vice president of clinical. Hill will be responsible for leading the company's clinical business segment, which includes early stage, phase II-IV and strategic resourcing.

Prior to joining inVentiv, Hill was CEO at PPD, where he successfully oversaw the process of taking the company private. Before that, he served as president of IMS Consulting Group, where he oversaw an aggressive strategy of organic and inorganic growth—building the business from $100 million in 2004 to $500 million in 2010. Prior to IMS, Hill held a series of other positions in pharmaceutical consulting.